Budesonide Inhaler is a corticosteroid used treat a range of breathing conditions including asthma. Corticosteroids work because they reduce swelling and irritation in the airways, making air flow easier in the lungs.
This report contains market size and forecasts of Budesonide Inhaler in global, including the following market information:
Global Budesonide Inhaler Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Budesonide Inhaler Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Budesonide Inhaler companies in 2021 (%)
The global Budesonide Inhaler market was valued at 4616.4 million in 2021 and is projected to reach US$ 5738.9 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dry Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Budesonide Inhaler include AstraZeneca, Cosmo Pharmaceuticals, Teva Pharmaceutical, Novartis, Mylan, Pfizer, Dr. Falk Pharma, Chiesi Farmaceutici and Orion Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Budesonide Inhaler manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Budesonide Inhaler Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Budesonide Inhaler Market Segment Percentages, by Type, 2021 (%)
Dry Powder
Suspension
Sprays
Global Budesonide Inhaler Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Budesonide Inhaler Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Budesonide Inhaler Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Budesonide Inhaler Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Budesonide Inhaler revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Budesonide Inhaler revenues share in global market, 2021 (%)
Key companies Budesonide Inhaler sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Budesonide Inhaler sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Cosmo Pharmaceuticals
Teva Pharmaceutical
Novartis
Mylan
Pfizer
Dr. Falk Pharma
Chiesi Farmaceutici
Orion Corporation
Cipla Limited
Bausch Health Companies
Takeda Pharmaceutical
Lupin Limited
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories